A detailed history of Apg Asset Management N.V. transactions in Eli Lilly & CO stock. As of the latest transaction made, Apg Asset Management N.V. holds 703,220 shares of LLY stock, worth $623 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
703,220
Previous 659,087 6.7%
Holding current value
$623 Million
Previous $513 Million 24.17%
% of portfolio
1.07%
Previous 0.84%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $32 Million - $40.1 Million
44,133 Added 6.7%
703,220 $637 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $25.1 Million - $33.6 Million
-42,444 Reduced 6.05%
659,087 $513 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $93.6 Million - $110 Million
-178,261 Reduced 20.26%
701,531 $409 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $37.4 Million - $51.5 Million
-85,956 Reduced 8.9%
879,792 $473 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $11.6 Million - $15.5 Million
-33,093 Reduced 3.31%
965,748 $453 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $33 Million - $38.8 Million
-106,286 Reduced 9.62%
998,841 $343 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $217 Million - $252 Million
673,761 Added 156.19%
1,105,127 $404 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $32 Million - $36.5 Million
-107,969 Reduced 20.02%
431,366 $142 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $19.7 Million - $23.2 Million
-70,737 Reduced 11.59%
539,335 $167 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $9.25 Million - $11.5 Million
-39,400 Reduced 6.07%
610,072 $157 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $120 Million - $149 Million
-533,900 Reduced 45.12%
649,472 $158 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $13.7 Million - $16.8 Million
-61,600 Reduced 4.95%
1,183,372 $236 Million
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $8.26 Million - $10.7 Million
-45,754 Reduced 3.54%
1,244,972 $241 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $52.7 Million - $68.2 Million
-320,820 Reduced 19.91%
1,290,726 $205 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $28.9 Million - $38.3 Million
221,829 Added 15.96%
1,611,546 $222 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $6.77 Million - $7.83 Million
46,318 Added 3.45%
1,389,717 $175 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $40.5 Million - $48.8 Million
296,984 Added 28.38%
1,343,399 $196 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $192 Million - $238 Million
-1,614,423 Reduced 60.67%
1,046,415 $145 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $276 Million - $341 Million
2,314,410 Added 668.08%
2,660,838 $307 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $32.7 Million - $40.4 Million
-305,401 Reduced 46.85%
346,428 $40.6 Million
Q3 2019

Nov 08, 2019

SELL
$106.79 - $116.16 $216 Million - $235 Million
-2,023,809 Reduced 75.64%
651,829 $66.9 Million
Q2 2019

Aug 13, 2019

BUY
$110.79 - $129.32 $1.64 Million - $1.91 Million
14,800 Added 0.56%
2,675,638 $260 Million
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $229 Million - $270 Million
2,060,000 Added 342.85%
2,660,838 $307 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $23.5 Million - $26.3 Million
222,000 Added 58.6%
600,838 $60.8 Million
Q3 2018

Nov 09, 2018

BUY
$85.86 - $107.31 $935,874 - $1.17 Million
10,900 Added 2.96%
378,838 $35 Million
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $3.14 Million - $3.61 Million
-41,500 Reduced 10.14%
367,938 $26.9 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $33.9 Million - $40.1 Million
-457,440 Reduced 52.77%
409,438 $25.8 Million
Q4 2017

Jan 24, 2018

SELL
$81.94 - $87.89 $18.1 Million - $19.4 Million
-221,126 Reduced 20.32%
866,878 $61 Million
Q3 2017

Oct 19, 2017

BUY
$77.07 - $85.54 $83.9 Million - $93.1 Million
1,088,004
1,088,004 $93.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $842B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.